Ross "Improved" Similac infant formula with increased nucleotides now launching.
This article was originally published in The Tan Sheet
Executive Summary
ROSS PRODUCTS "IMPROVED" SIMILAC INFANT FORMULA LAUNCHING NATIONWIDE in May with increased levels of nucleotides and a new fat blend and protein system, the Columbus, Ohio-based division of Abbott Labs said. Improved Similac infant formula contains 72 mg of nucleotides; "the level of nucleotides in any other infant formula...is less than half the total potentially available nucleotides found in improved Similac and breast milk," Ross stated. The reformulated product is replacing the former version.
You may also be interested in...
Similac Superiority Claims Over Enfamil Should Be Modified – NAD
Marketing claims that Similac and SimilacAdvance are "'the best' and superior to Enfamil and Enfamil Lipil in terms of a baby's mental development and visual acuity" should be discontinued, the National Advertising Division says in a recent decision
Similac Superiority Claims Over Enfamil Should Be Modified – NAD
Marketing claims that Similac and SimilacAdvance are "'the best' and superior to Enfamil and Enfamil Lipil in terms of a baby's mental development and visual acuity" should be discontinued, the National Advertising Division says in a recent decision
Similac Superiority Claims Over Enfamil Should Be Modified – NAD
Marketing claims that Similac and SimilacAdvance are "'the best' and superior to Enfamil and Enfamil Lipil in terms of a baby's mental development and visual acuity" should be discontinued, the National Advertising Division says in a recent decision